RecruitingNot applicableNCT07316855
Evaluating the Feasibility of Bioresorbable Iron-Based Covered Stent: A Clinical Trial
Studying OBSOLETE: Autosomal dominant coarctation of aorta
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Shubo Song
- Principal Investigator
- Taibing Fan, MDChinese Academy of Medical Sciences, Fuwai Hospital
- Intervention
- Implantation of Bioresorbable Iron-based Covered Aortic Stent(device)
- Enrollment
- 10 enrolled
- Eligibility
- 1-60 years · All sexes
- Timeline
- 2024 – 2027
Study locations (1)
- Fuwai Central China Cardiovascular Hospital, Zhengzhou, Henan, China
Collaborators
Central China Fuwai Hospital of Zhengzhou University
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07316855 on ClinicalTrials.govOther trials for OBSOLETE: Autosomal dominant coarctation of aorta
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT07134621Target Organ Damage in Patients With Repaired Coarctation of Aorta and Exercise Induced HypertensionUniversity Medical Centre Ljubljana
- ENROLLING BY INVITATIONNCT05880576The Arch Watch Study: An Integrated Evaluation of Hemodynamics in Infants With Suspected Coarctation of the AortaBoston Children's Hospital
- RECRUITINGNCT06759103Electronic Archive of Patients With Diagnosis and Suspected Prenatal Diagnosis of Aortic CoarctationIRCCS Azienda Ospedaliero-Universitaria di Bologna
- ACTIVE NOT RECRUITINGNANCT05086016Growth Trial: Study of the Renata Minima StentRenata Medical
- ACTIVE NOT RECRUITINGNCT05362721PV Loop & Coarctation StudyUniversity of Minnesota
See all trials for OBSOLETE: Autosomal dominant coarctation of aorta →